Stonepine Capital Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Stonepine Capital Management, LLC disclosed 38 US equity positions worth $158.2m in its Q3 2024 13F filing. The largest position was ADMA at 23.6% of the reported book, followed by EOLS and LKFT.
What did Stonepine Capital Management, LLC own in Q3 2024? Top 38 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ADMA ADMA BIOLOGICS INC | Healthcare | 23.6% | $37.4m | 1,870,000 | – | |
| 2 | EOLS EVOLUS INC | Healthcare | 14.0% | $22.2m | 1,369,821 | – | |
| 3 | LKFT GALAPAGOS NV | Healthcare | 8.7% | $13.8m | 478,659 | – | |
| 4 | JAZZ JAZZ PHARMACEUTICALS PLC US LISTED | Healthcare | 3.9% | $6.1m | 55,000 | – | |
| 5 | RPRX ROYALTY PHARMA PLC | Healthcare | 3.8% | $6.0m | 212,000 | – | |
| 6 | XOMA CORP | 3.3% | $5.2m | 195,096 | – | ||
| 7 | RIGL RIGEL PHARMACEUTICALS INC | 3.2% | $5.0m | 309,100 | – | ||
| 8 | ZVRA ZEVRA THERAPEUTICS INC | 3.1% | $4.9m | 700,000 | – | ||
| 9 | ANIK ANIKA THERAPEUTICS INC | Healthcare | 3.0% | $4.7m | 189,308 | – | |
| 10 | RVNCEUR REVANCE THERAPEUTICS INC | 2.7% | $4.3m | 820,000 | – | ||
| 11 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 2.6% | $4.1m | 1,000,000 | – | |
| 12 | VSTM VERASTEM INC | Healthcare | 2.5% | $3.9m | 1,310,287 | – | |
| 13 | OPTINOSE INC | 2.4% | $3.8m | 5,688,590 | – | ||
| 14 | URGN UROGEN PHARMA LTD | Healthcare | 2.2% | $3.6m | 280,345 | – | |
| 15 | SCPH SCPHARMACEUTICALS INC | 2.2% | $3.6m | 778,874 | – | ||
| 16 | ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 2.1% | $3.2m | 75,000 | – | |
| 17 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 1.9% | $3.0m | 196,895 | – | |
| 18 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 1.8% | $2.9m | 205,675 | – | ||
| 19 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 1.8% | $2.8m | 2,458,873 | – | |
| 20 | TELA TELA BIO INC | 1.8% | $2.8m | 1,110,000 | – | ||
| 21 | INDIVIOR PLC | 1.7% | $2.6m | 270,000 | – | ||
| 22 | XGN EXAGEN INC | 1.0% | $1.7m | 534,398 | – | ||
| 23 | MIST MILESTONE PHARMACEUTICALS IN | 1.0% | $1.5m | 999,790 | – | ||
| 24 | SRZN SURROZEN INC | 0.8% | $1.3m | 110,000 | – | ||
| 25 | AYTU AYTU BIOPHARMA INC | 0.7% | $1.2m | 500,958 | – | ||
| 26 | KEZAR LIFE SCIENCES INC | 0.7% | $1.2m | 1,491,305 | – | ||
| 27 | ACET ADICET BIO INC | Healthcare | 0.6% | $877.6k | 609,446 | – | |
| 28 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 0.5% | $822.6k | 88,457 | – | |
| 29 | FNAUSD PARAGON 28 INC | 0.5% | $766.4k | 114,724 | – | ||
| 30 | KPRX KIORA PHARMACEUTICALS INC | 0.5% | $740.8k | 202,400 | – | ||
| 31 | PYPD POLYPID LTD | 0.3% | $476.5k | 138,504 | – | ||
| 32 | TSVT* 2SEVENTY BIO INC | 0.3% | $472.0k | 100,000 | – | ||
| 33 | MYO MYOMO INC | 0.3% | $401.0k | 100,000 | – | ||
| 34 | APRE APREA THERAPEUTICS INC | 0.2% | $377.2k | 137,174 | – | ||
| 35 | 2662247D ITEOS THERAPEUTICS INC | 0.2% | $306.3k | 30,000 | – | ||
| 36 | TENX TENAX THERAPEUTICS INC | 0.1% | $173.0k | 50,000 | – | ||
| 37 | RYI VIRACTA THERAPEUTICS INC | 0.1% | $115.7k | 500,000 | – | ||
| 38 | ALIMERA SCIENCES INC CVR | 0.1% | $96.3k | 2,408,469 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.